Gauri Lamture

Gauri Lamture, PhD, is a gene therapy reviewer at CBER in FDA.

Articles by Gauri Lamture

Global shipping and supply chain vector illustration. Abstract concept with world map background and connected icons related to international import / export, distribution and transportation. | Image credit: © j-mel - © j-mel - stock.adobe.com

FDA, Genentech, Minaris Panelists Detail Raw Material Risk Strategies for Advanced Therapies

ByFeliza Mirasol,Lori Dingledine,Athenesia Faggins,Gauri Lamture,Marc Glogovsky

September 17th 2026

Panelists from FDA, Genentech, and Minaris discussed raw material risk, supplier oversight, and at-risk release strategies for advanced therapies at the PDA/FDA Joint Regulatory Conference.

Gauri Lamture

Articles by Gauri Lamture

FDA, Genentech, Minaris Panelists Detail Raw Material Risk Strategies for Advanced Therapies

Latest Updated Articles